Literature DB >> 11994276

Dopamine transporters are phosphorylated on N-terminal serines in rat striatum.

James D Foster1, Benchaporn Pananusorn, Roxanne A Vaughan.   

Abstract

Dopamine transporters (DATs) are neuronal phosphoproteins that clear dopamine from the synaptic cleft. Activation of protein kinase C (PKC) and inhibition of protein phosphatases by okadaic acid (OA) increase phosphorylation of DAT and lead to concomitant reduction in DAT activity and cell surface expression. Numerous potential sites for phosphorylation are present on DAT, but the sites utilized and their relationship to transport regulation are currently unknown. We used peptide mapping and epitope-specific immunoprecipitation to identify the region of DAT that undergoes phosphorylation in rat striatal tissue. Phosphoamino acid analysis revealed that basal and stimulated samples were phosphorylated primarily on serine. Digestion of (32)PO(4)-labeled DAT with trypsin and immunoprecipitation with N- or C-terminal specific antisera failed to isolate phosphopeptide fragments corresponding to photoaffinity-labeled fragments that contain all internal interhelical loops. However, digestion of (32)PO(4)-labeled DAT with endoproteinase asp-N and immunoprecipitation with an N-terminal antiserum extracted two phosphopeptide fragments from both basal and PKC/OA-stimulated samples, demonstrating that the N-terminal cytoplasmic tail is a major site of phosphorylation. Aminopeptidase treatment of PKC- and/or OA-stimulated DAT cleaved essentially all (32)PO(4) label without proteolysis extending past transmembrane domains 1 and 2, providing further evidence that most phosphorylation sites are near the N terminus and not in intracellular loops or C-terminal domains. In situ proteolysis of the N-terminal tail indicates that the majority of stimulated phosphorylation sites are N-terminal to an antibody epitope at residues 42-59. Two-dimensional analysis of purified protein produced three tryptic phosphopeptides that may result from phosphorylation of multiple sites, but the fragments did not co-migrate with synthetic tryptic peptides phosphorylated at serines 2 and 4. These results indicate that most or all of the basal and stimulated phosphorylation of DAT in striatal tissue occurs on one or more residues in a group of six serines clustered near the distal end of the cytoplasmic N terminus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994276     DOI: 10.1074/jbc.M200294200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

Review 1.  Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6.

Authors:  Nian-Hang Chen; Maarten E A Reith; Michael W Quick
Journal:  Pflugers Arch       Date:  2003-04-29       Impact factor: 3.657

Review 2.  Vesicular and plasma membrane transporters for neurotransmitters.

Authors:  Randy D Blakely; Robert H Edwards
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 3.  The solute carrier 6 family of transporters.

Authors:  Stefan Bröer; Ulrik Gether
Journal:  Br J Pharmacol       Date:  2012-09       Impact factor: 8.739

4.  Dysregulation of dopamine transporters via dopamine D2 autoreceptors triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder.

Authors:  Erica Bowton; Christine Saunders; Kevin Erreger; Dhananjay Sakrikar; Heinrich J Matthies; Namita Sen; Tammy Jessen; Roger J Colbran; Marc G Caron; Jonathan A Javitch; Randy D Blakely; Aurelio Galli
Journal:  J Neurosci       Date:  2010-04-28       Impact factor: 6.167

5.  Syntaxin 1A regulates dopamine transporter activity, phosphorylation and surface expression.

Authors:  M A Cervinski; J D Foster; R A Vaughan
Journal:  Neuroscience       Date:  2010-07-17       Impact factor: 3.590

6.  Environmental enrichment enhances synaptic plasticity by internalization of striatal dopamine transporters.

Authors:  Myung-Sun Kim; Ji Hea Yu; Chul Hoon Kim; Jae Yong Choi; Jung Hwa Seo; Min-Young Lee; Chi Hoon Yi; Tae Hyun Choi; Young Hoon Ryu; Jong Eun Lee; Bae Hwan Lee; Hyongbum Kim; Sung-Rae Cho
Journal:  J Cereb Blood Flow Metab       Date:  2015-11-02       Impact factor: 6.200

7.  Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.

Authors:  Amy K Wagner; Laura L Drewencki; Xiangbai Chen; F Ryan Santos; Amina S Khan; Rashed Harun; Gonzalo E Torres; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

8.  Three ubiquitin conjugation sites in the amino terminus of the dopamine transporter mediate protein kinase C-dependent endocytosis of the transporter.

Authors:  Manuel Miranda; Kalen R Dionne; Tatiana Sorkina; Alexander Sorkin
Journal:  Mol Biol Cell       Date:  2006-11-01       Impact factor: 4.138

9.  Proline-directed phosphorylation of the dopamine transporter N-terminal domain.

Authors:  Balachandra K Gorentla; Amy E Moritz; James D Foster; Roxanne A Vaughan
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

10.  Protein kinase Cβ is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter.

Authors:  Rong Chen; Conor P Daining; Haiguo Sun; Rheaclare Fraser; Stephanie L Stokes; Michael Leitges; Margaret E Gnegy
Journal:  J Neurochem       Date:  2013-03-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.